February 23, 2021
Finnish digital health startup Popit and global healthcare engagement firm Ashfield Engage have announced a collaboration to improve patient adherence.
Popit’s monitoring technology, and Ashfield Engage’s patient support programme have been brought together to provide personalised support to patients on oral solid dosage (OSD) treatments.
The Popit Sense device is attached to a pill sheet and...
December 3, 2020
As the UK prepares for its greatest mass vaccination programme, doctors have raised concerns about the IT system for booking and recall of patients.
A COVID-19 vaccine developed by Pfizer/BioNTech is due to be rolled out next week after being approved for use by the Medicines and Healthcare Regulatory Authority (MHRA) yesterday.
But questions remain about logistics of the vacation programme,...
September 4, 2020
Connected-care-device and services company VivaLNK has partnered with healthcare engineering and tech firm Mazzetti to supply pop-up hospitals, clinics and senior centers with patient monitoring tools. These include VivaLNK's wearable vitals sensors and a connected provider platform, which the companies say will help reduce unnecessary disease exposures within these settings.
“As the pandemic...
June 29, 2020
Nordic digital therapeutics company SidekickHealth is partnering with pharma giant Pfizer to launch a digital therapeutics platform, in a deal thought to be worth more than $8 million.
The solution combines scientific expertise and digital technologies, giving patients a tool to help them maintain healthy lifestyles and improve their disease management and quality of life, while providing...
November 27, 2019
Espoo, Finland-based Popit, maker of a smart pill tracker, has revealed this month that it is teaming up with Swiss pharma giant Novartis in an initiative aiming to improve patients' adherence to medication. The announcement follows the startup's work with Pfizer to support patients receiving treatment for rheumatoid arthritis.
Last week, at Slush, MobiHealthNews sat down with Popit cofounder and...
October 9, 2019
Patient engagement has long been a tough nut for healthcare to crack, and it’s not for a lack of trying. New technologies that meet the patient in their home offer a clear opportunity to meet patients throughout the course of their daily lives, but the tools themselves are only half of the solution — making a real connection is just as much about addressing and responding to each individual’s...
July 3, 2019
Diving deeper into digital, this quarter the pharma giants have continued to implement new tools to enhance clinical trials, support medication management with technology and partner in developing digital therapeutics.
Onc, a foreign entity to this established industry, pharma executives are now becoming better versed in working with digital health companies and sharing the lessons they've...
May 21, 2019
This morning Verily announced a series of new strategic partnerships with four global pharmaceutical companies that will bring low-burden digital data collection and analysis tools to clinical research projects.
Alongside Novartis, Otsuka, Pfizer and Sanofi, the Alphabet subsidiary will employ its Project Baseline platform to increase the number and diversity of study populations by making it...
April 9, 2019
Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses, is racking up the pharma partnerships as of late. Just weeks after the artificial intelligence company agreed to a multi-year deal with Bristol-Myers Squibb, Concerto announced this morning a similar project with Pfizer that will support the latter’s research on precision oncology...
February 20, 2019
Looking to innovate in the research space, pharma giant Pfizer inked a deal with Ochsner Health System, a Louisiana academic healthcare system, to develop digital tools for clinical trials. The partners will be using Ochsner’s innovation lab, innovationOchsner, and Ochsner Research.
The multi-year strategic alliance revolves around a goal of improving “access and connectivity to clinical trials...